Skip to content

Insider · CIK 0001360968

Randy Milby

ceoofficerdirector

Files at CNTN (Tharimmune, Inc.). First filing Dec 4, 2023, latest Dec 20, 2024.

In brief

Randy Milby files SEC Form 4 as CEO and director at CNTN (Tharimmune, Inc.). Since Dec 4, 2023, Randy Milby has reported 3 open-market buys worth $34k and 0 open-market sells worth $0, the latest filed on Dec 20, 2024.

A track record needs three past buys with six months of prices behind them; Randy Milby has 0, so none is measured yet.

The newest scored trade: bought $9,752 of CNTN on Dec 19, 2024, filed Dec 20, 2024, scored 31 (weak).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
3 / 0
$34k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CNTN: Tharimmune, Inc.

CNTNOct 9, 2026 · close 2.11

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
31Weak
CNTNbuy
Tharimmune, Inc.
$9,752
4,600 shares
+36%-
44Moderate
CNTNbuy
Tharimmune, Inc.
$15k
29,000 shares
+23%+14% from low-99% from high
46Moderate
CNTNbuy
Tharimmune, Inc.
$10k
10,000 shares
+9%0% from low-98% from high

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 19, 2024CNTN
Tharimmune, Inc.
POpen-market purchase
Common Stock
+4,600$2.12$9,75217,534Dec 20, 2024
Dec 15, 2023CNTN
Tharimmune, Inc.
POpen-market purchase
Common Stock
+29,000$0.50$15k156,517Dec 18, 2023
Nov 30, 2023CNTN
Tharimmune, Inc.
POpen-market purchase
Common Stock
+10,000$1.00$10k127,517Dec 4, 2023

Questions about Randy Milby

Answered from the filings on this page, as of the latest one.

Is Randy Milby buying or selling?

Not in the last 12 months. Randy Milby's latest open-market trade on SEC Form 4 was bought $9,752 of CNTN on Dec 19, 2024.

How did Randy Milby's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Randy Milby has 0.

Where does Randy Milby file Form 4?

Randy Milby has filed Form 4 at CNTN (Tharimmune, Inc.) as CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Randy Milby: insider trades and track record | InsiderTell